A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

Autor: Gallage, Suchira 1, 2, 13, ∗, Ali, Adnan 1, 13, Barragan Avila, Jose Efren 1, Seymen, Nogayhan 3, Ramadori, Pierluigi 1, 2, Joerke, Vera 4, Zizmare, Laimdota 4, 9, Aicher, David 2, Gopalsamy, Indresh K. 2, Fong, Winnie 2, Kosla, Jan 1, Focaccia, Enrico 1, Li, Xin 1, Yousuf, Suhail 5, Sijmonsma, Tjeerd 1, Rahbari, Mohammad 1, 6, Kommoss, Katharina S. 1, 7, Billeter, Adrian 5, Prokosch, Sandra 1, Rothermel, Ulrike 1, Mueller, Florian 1, Hetzer, Jenny 1, Heide, Danijela 1, Schinkel, Benjamin 2, Machauer, Tim 1, Pichler, Bernd 4, 9, 12, Malek, Nisar P. 2, 8, 9, Longerich, Thomas 10, Roth, Susanne 5, Rose, Adam J. 11, Schwenck, Johannes 4, 9, 12, Trautwein, Christoph 2, 4, 9, Karimi, Mohammad M. 3, Heikenwalder, Mathias 1, 2, 9, 14, ∗∗
Zdroj: In Cell Metabolism 4 June 2024 36(6):1371-1393
Databáze: ScienceDirect